A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
Time · 56 minutes ago

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
Continue reading at Time →









